Quarterly report pursuant to Section 13 or 15(d)

Earnings per Share - Additional Information (Detail)

v3.23.3
Earnings per Share - Additional Information (Detail) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Share-based compensation expense     $ 1,938 $ 1,886
Performance Stock Units (PSU) [Member]        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Antidilutive securities excluded from calculation of diluted earnings per share 54,765   50,460  
Performance Stock Units (PSU) [Member] | 2021 Equity Compensation Plan        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Total fair value of the PSUs     $ 1,100 $ 1,000
Share-based compensation arrangement by share-based payment award, additional shares issued     53,696 38,036
Stock options, expiration term from date of grant     3 years  
Share Based Compensation shares vested to executive officer     35,906  
Share-based compensation arrangement by share based payment award, performance stock units outstanding 134,358 104,599 134,358 104,599
Share-based compensation arrangement by share based payment award, performance stock units aggregate grant fair value     $ 2,900 $ 2,000
Employee Stock Option        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Dilutive securities excluded from calculation of diluted earnings per share 61,000   61,000  
Antidilutive securities excluded from calculation of diluted earnings per share   0 0